Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Multikinase Inhibition with Tinengotinib in Advanced Solid Tumors: Results from a Multicenter Phase Ib/II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 20, 2026
Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial.
Journal: Journal of the National Cancer Institute
Published: November 24, 2025
Estrogen Plus Progestin and Colorectal Cancer: Long-Term Findings From the Women's Health Initiative Randomized Clinical Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 19, 2024
Randomized trials of estrogen-alone and breast cancer incidence: a meta-analysis.
Journal: Breast cancer research and treatment
Published: February 19, 2024
UGT1A1*28 polymorphism and the risk of toxicity and disease progression in patients with breast cancer receiving sacituzumab govitecan.
Journal: Cancer medicine
Published: December 13, 2023
Locoregional Treatment for Early-Stage Breast Cancer: Current Status and Future Perspectives.
Journal: Current oncology (Toronto, Ont.)
Published: May 26, 2023
Lasofoxifene versus fulvestrant for ER+/HER2- metastatic breast cancer with an ESR1 mutation: results from the randomized, phase II ELAINE 1 trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 25, 2023
Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer.
Journal: Journal of clinical medicine
Published: February 09, 2023
HER2-targeted antibody-drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia.
Journal: Breast cancer (Tokyo, Japan)
Published: February 02, 2023
Estrogen therapy and breast cancer in randomized clinical trials: a narrative review.
Journal: Menopause (New York, N.Y.)
Published: August 15, 2022
Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancer.
Journal: Cancer
Published: August 09, 2022
Last Updated: 09/26/2026